News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski
Jul 9, 2025, 09:12

Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Case report of the use of teclistamab for treatment of relapsed/refractory POEMS syndrome producing a durable biochemical and radiographic remission lasting past drug discontinuation and without any unanticipated toxicities.”

Title: Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome

Authors: Alexis Talbot, Nathalie Forgeard, Tristan Vaugeois, Floriane Theves, Sabrine Dimassi, Bruno Royer, Pierre-Edouard Debureaux, Véronique Meignin, Laetitia Vercellino, David Boutboul, Bertrand Arnulf, Stéphanie Harel

You can read the Full Article in Haematologica.

Myeloma Paper of the Day, July 9th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Alexis Talbot Bertrand Arnulf Bruno Royer cancer David Boutboul Floriane Theves Laetitia Vercellino Myeloma Myeloma Paper of the Day Nathalie Forgeard OncoDaily Oncology Pierre-Edouard Debureaux POEMS syndrome Robert Orlowski Sabrine Dimassi Stephanie Harel teclistamab Tristan Vaugeois Véronique Meignin
Special Coverage
Insight
Jul 29, 2025, 20:10
Zainab Shinkafi-Bagudu: The Significant Impact of the Bone Cancer on Young Adults
Blog
Jul 29, 2025, 18:17
World Hepatitis Day: A Voice You Need to Hear - ELPA
Blog
Jul 29, 2025, 18:00
The 5th Episode of the APAC Lung Cancer Consensus Video Series - ASPIRE for Lung Cancer
Blog
Jul 29, 2025, 17:38
How Collaboration Can Help Close Gaps and Improve Access to Care - ACREOL Global
Blog
Jul 29, 2025, 17:06
Working to Better Understand and Detect ALD-HCC - GENIAL-Horizon Europe
Insight
Jul 29, 2025, 15:41
Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss
Oncolibrary
Jul 29, 2025, 12:29
New Paper Alert: TUXEDO-3 Trial Demonstrates Clinical Activity of Patritumab Deruxtecan in Leptomeningeal Metastases from Solid Tumors
Insight
Jul 29, 2025, 11:49
Why Do Viruses Act So Differently? - Sbarro Health Research Organization
Insight
Jul 29, 2025, 11:22
Miguel Bronchud: Prostate Cancer Treatments Continue to Evolve
Blog
Jul 29, 2025, 11:19
Afreen Shariff: How Lack of Common Language Creates Confusion in Medicine
Blog
Jul 29, 2025, 11:18
How Immune Cells Could be Undermining the Cancer-fighting Ability of Engineered Cell Therapies - MSKCC
Blog
Jul 29, 2025, 11:05
Voice of the Families: Mahlet and Her Father - CANCaRe Africa